The in viva distribution of [3H
The in viva distribution of [3H]scopolamine in rat brain following establishment of constant, saturating arterial tracer concentrations was examined with the use of quantitative autoradiography.
The equilibrium drug distribution, studied 240 min after initiation of tracer infusion, was highly correlated with the regional density of muscarinic receptor sites determined in vitro in the same animals by autoradiographic analysis of [3H]quinuclidinyl benzilate binding. Brain regions of highest receptor density were generally correlated with known terminal fields of cholinergic neurons, and they demonstrated a protracted time course of in viva labeling. An exception was noted in the basal pons, where a receptor population of high density without documented cholinergic innervation was rapidly labeled. It is suggested that synaptic muscarinic receptors are labeled slowly, as a consequence of either restricted tracer accessibility or competition between tracer and endogenous acetylcholine for available binding sites, and that the pontine receptors may be functionally distinct from those in other brain regions. The in viva equilibrium binding technique used in the present study results in regional tissue radioligand concentrations directly proportional to receptor density and may, thus, provide a basis for receptor imaging in the human brain by means of positron emission tomography. (Reisine et al., 1977; Hornykiewicz, 1982) Huntington's disease (Enna et al., 1976; Wastek and YamaReceived October 12, 1984; Revrsed January 25, 1985; Accepted February 8, 1985 ' in rats under lrght diethyl ether anesthesia. Animals were allowed to recover for 3 to 4 hr before initiation of binding experiments.
[3H]Scopolamine was administered intravenously as a bolus of unit magnrtude followed by infusion at a rate of 0.04 unit/min. A total of 15 mCi/kg (0.5 bmol/kg) was given over 240 min. This protocol has been shown previously to result in constant arterial plasma levels of scopolamrne of approximately 20 nM, which saturate cerebral muscarinic receptors (Frey et al., 1985) . Timed samples of arterial plasma were obtained for measurement of [3H]scopolamine and labeled metabolites. At the termination of the infusion period, animals were killed by decapitation and samples of whole blood, plasma, and lrver were obtarned. The brain was rapidly dissected and a portion of the frontal pole was removed for chromatographic analysis. The remainder was drvided coronally, caudal to the inferrer colliculus, and the two ttssue blocks were mounted on brass microtome chucks, frozen with crushed dry ice, and stored at -70°C.
2407 Vol. 5, No. 9, Sept. 1985 (Frey et al., 1985) . Brain samples were weighed and homogenized in 10 vol of 80% ethanol and centrifuged at 15,000 x g for 10 min. Plasma samples were mixed wrth 3 vol of 95% ethanol and centrifuged.
Aliquots of the ethanol supernatants were analyzed for nonvolatile radroactivity followrng drying at 80°C. Scopolamine content of the nonvolatile fraction was determined by thin-layer chromatography.
Alrquots of the ethanol supernatants were concentrated by vacuum dessication and chromatographed wtth carrier scopolamine (0.3 mg) on silica gel plates coated with a fluorescent indicator (Merck F 254), using the solvent system tetrahydrofuran-diisopropylethylamine, 95:5. Scopolamine was located by fluorescence quench and quantitated by scintillation counting. Selected plates were sprayed with Er?hance and exposed to Kodak XRP-5 x-ray film for 1 to 4 weeks.
Striatal lesions. Unilateral striatal lesions were produced by stereotaxic injection of the excitatory neurotoxin ibotenrc acrd. Animals were anesthetized with diethyl ether and mounted in a stereotaxic frame with reference planes according to the atlas of Konig and Klippel (1963) . Twenty micrograms of ibotenic acid in a volume of 1 ~1 were injected over a period of 8 min through a 30 gauge steel cannula positioned at the following coordinates: 1 .O mm anterior to the bregma, 2.6 mm lateral to the midline, and 5.5 mm below the dura. The cannula was left in place for an additional 2 min following the injection to minimize reflux of ibotenate up the cannula track.
Results
Autoradiography of in vivo scopolamine distribution. In vivo binding of scopolamine 240 min after initiation of the tracer infusion revealed regional variations consistent with previous regional dissection experiments (Frey et al., 1985) . As anticipated, further heterogeneity in tracer distribution was observed within discrete anatomic regions (Fig. 1) Fig. 4A ). By contrast, the correlation between the same in vivo tracer distribution and rates of local cerebral blood flow (Sakurada et al., 1978) was poor (r* = 0.21). represented approximately 50% of the nonvolatile activity and in samples of liver it represented less than 10%. The time courses of labeled scopolamine as well as of two major metabolites in plasma are presented in Figure 7 . Both labeled metabolites approached apparent steady-state levels after 60 min, suggesting a balance between production on the one hand and excretion or further metabolic degradation on the other.
Discussion
Relationship between in vivo scopolamine binding and muscarinic receptor density.
Results obtained in the present autoradiographic experiments confirm the findings of previous regional dissection studies (Frey et al., 1985) Although quantitative autoradiography has been employed extensively in the past in the study of the cerebral distribution of p--emitting radiotracers (Freygang and Sokoloff, 1958; Reivich et al., 1969; Sokoloff et al., 1977) , application of the method to measurement of tritiated compounds has emerged only recently (FaracoCantin et al., 1980; Penney et al., 1981) . A major distinction between quantitation of tritium and higher energy isotopes is that the firange of the former is short compared to the thickness of tissue sections, compared with that of '?, 35S, 32P, or 13'1, Thus, although less important in quantitation of higher energy isotopes, regional differences in tissue density may influence the apparent concentrations of tritium in brain underlying the autoradiographic film. In particular, it has been demonstrated that the differential lipid contents of gray and white matter contribute to a relative underestimation of tritium concentration of approximately 60% in the latter tissue (Alexander et al., 1981) . Thus, a portion of the apparent anatomic correlation between in vivo and in vitro tracer autoradiograms presented here may reflect regional lipid content. Additionally, it may be speculated that rinsing of unfixed, slide-mounted tissue sections alters tissue attenuation properties by removal of water-soluble substances. This effect may explain in part a greater apparent binding of [3H]QNB than of [3H]scopolamine in regions of high receptor density. Notwithstanding these considerations, the most significant influence on equilibrium binding of scopolamine appears to be the local muscarinic receptor concentration. The autoradiographic results obtained in the present study demonstrate a linear relationship between muscarinic receptor density and the in vivo equilibrium distribution of [3H]scopolamine over a IO-fold range of receptor densities in the various brain regions examined.
Metabolism
of scopolamine.
Several labeled metabolites of [Nmethy/-3H]scopolamine
have been observed following intravenous administration.
In a previous study, the predominant metabolite fraction in plasma and brain was detected as volatile radioactivity (Frey et al., 1985) . The probable source of volatile 3H from the [Nmethy/-3H]scopolamine used is the result of N-demethylation and subsequent oxidation of labeled formaldehyde to [3H]H20 and formate, although tritium exchange as a source of labeled water cannot be ruled out. In the present study, several nonvolatile metabolites were observed by thin layer chromatography of tissue extracts. Although none were characterized further, the migration pattern of these compounds indicates increased polarity, suggesting oxidation to acidic forms, glucuronide conjugation, or both. Since more polar compounds than the parent molecule are essentially excluded from entry into the brain, we interpret nonvolatile activity in the brain as indicative of [3H]scopolamine content. Relationship of muscarinic receptors to cholinergic innervation. The regional distribution of muscannic receptors determlned both in vitro and in vivo in the present work is in general agreement with previous regional dissection ( Kobayashi et al., 1978) , as well as autoradiographic in vitro studies (Rotter et al., 1979a, b; Wamsley et al., 1980 Wamsley et al., , 1981 . A close correspondence between areas of high receptor density and the distribution of terminal fields of cholinergic neurons is observed in most brain regions. Thus, receptors observed in the olfactory tubercle, neocortex, hippocampus, and basolateral amygdala may represent the anticipated postsynaptic sites innervated by the basal forebrain cholinergic system (Johnston et al., 1981; Fibiger, 1982; McKinney et al., 1983; Mesulam et al., 1983) . Similarly, the observed receptor density in the striatum correlates well with the presence of cholinergic interneurons, the presence of which accounts for the high levels of choline acetyltransferase activity and acetylcholine in the basal ganglia (McGeer et al., 1971) . Although receptor densities in the thalamic nuclei are generally lower than those discussed above, the findings again appear to correlate with the reported density of cholinergic terminals (Mesulam et al., 1983) . Thus, nuclei with documented cholinergic innervation, e.g., the anteroventral and intralaminar nuclei, have significantly greater receptor densities than do the surrounding nuclei. In the brainstem and spinal cord, the receptor densities associated with the motor neuron pools may correspond to synapses of recurrent collaterals of the motor neurons on inhibitory interneurons (Renshaw cells). The binding observed in the basal pontine nuclei does not correspond to any known cholinergic innervation. It is interesting to I .Dte, however, that these binding sites are predominantly of the high affinity agonist type when studied by in vitro homogenate techniques, as opposed to the former receptor locations which demonstrate a large proportion of the low affinity receptor conformation (Birdsall et al., 1980) . The binding sites in the pons thus may be functionally distinct from those in the forebrain.
Time course of equilibration of scopolamine with muscarinic receptors. In the autoradiographic imaging studies performed at 60 min after initiation of the infusion, it was observed that the brain regions of greatest in vitro receptor density diverged more from the expected labeling levels at 240 min than did regions of intermediate 
